Corran Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 61.06%
- Profit Growth 121.17%
- Ebitda 526.11%
- Net Worth 31.53%
- Total Assets 11.13%
About Corran Pharma
Corran Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2018 (Six years and ten months 27 days old ). Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Ansh Bio Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Jadhav and Pooja Chavan serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC305930
- Company No.
305930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2018
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Corran Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Jadhav  | Director | 06-Mar-2018 | Current |
| Pooja Chavan | Director | 24-Dec-2020 | Current |
Financial Performance of Corran Pharma.
Corran Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.06% increase. The company also saw a substantial improvement in profitability, with a 121.17% increase in profit. The company's net worth Soared by an impressive increase of 31.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corran Pharma?
In 2021, Corran Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Corran Pharma?
Unlock and access historical data on people associated with Corran Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corran Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corran Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
